Home A single center experience in 90 cases with nonimmune hydrops fetalis: diagnostic categories ‒ mostly aneuploidy and still often idiopathic
Article
Licensed
Unlicensed Requires Authentication

A single center experience in 90 cases with nonimmune hydrops fetalis: diagnostic categories ‒ mostly aneuploidy and still often idiopathic

  • Julia Sturm ORCID logo EMAIL logo , Heiko Milera , Stephanie Essmann , Anja Fruth , Antje Jahn-Eimermacher , Mareike Selig , Jennifer Winter , Larissa Seidmann , Christoph Kampmann , André Kidszun , Eva Mildenberger and Catharina Whybra
Published/Copyright: April 11, 2022

Abstract

Objectives

The prognosis of nonimmune hydrops fetalis (NIHF) is still poor with a high mortality and morbidity rate despite progress in perinatal care. This study was designed to investigate etiology and outcome of NIHF.

Methods

A retrospective review of 90 NIHF cases from 2007 to 2019 was conducted at University Medical Center of the Johannes Gutenberg University, Mainz, Germany. Demographics, genetic results, prenatal and postnatal outcomes including one year survival as well as autopsy data were extracted. Etiology of hydrops was classified using 13 previously established categories. In 4 patients observed between 2016 and 2019, we used a next-generation-sequencing (NGS) panel for genetic evaluation.

Results

Ninety NIHF cases were identified, with a median gestational age (GA) at diagnosis of 14 weeks. There were 25 live-born infants with a median GA of 34 weeks at birth, 15 patients survived to one year. There was aneuploidy in more than one third of the cases. All 90 cases were subclassified into etiologic categories with chromosomal 35, idiopathic 15, syndromic 11, cardiovascular 9, inborn errors of metabolism 6, lymphatic dysplasia 3, thoracic 3, infections 3, gastrointestinal 3 and hematologic 2. The NGS panel was used in 4 cases and 4 diagnoses were made.

Conclusions

In 90 cases with NIHF we identified an aneuploidy in more than one third of the cases. Improved techniques, such as possibly specific genetic analysis, could reduce the high rate of unexplained cases of NIHF.


Corresponding author: Julia Sturm, Department of Neonatology of the Johannes Gutenberg University, Mainz, Germany, Phone: +49 6131 17 5892, E-mail:

Acknowledgments

This publication uses data collected within the framework of the doctoral thesis of Stephanie Essmann and Heiko Milera.

  1. Research funding: None declared.

  2. Author contributions: Heiko Milera, Department of Neonatology of the Johannes Gutenberg University, Mainz, Germany, was responsible for designing the protocol, extracting and analyzing data and interpreting results. Stephanie Essmann, Department of Neonatology of the Johannes Gutenberg University, Mainz, Germany, was responsible for designing the protocol, extracting and analyzing data and interpreting results. Anja Fruth, Department of Obstetrics and Gynecology of the Johannes Gutenberg University, Mainz, Germany, contributed to data extraction and provided feedback on the report. Antje Jahn-Eimermacher, Department of Mathematics and Natural Sciences, Darmstadt University of Applied Sciences, contributed to extracting and analyzing data, interpreting results and creating tables and figures. Mareike Selig, Institute of Human Genetics of the Johannes Gutenberg University, Mainz, Germany, contributed to data extraction, wrote passage 2.4. and provided feedback on the report. Jennifer Winter, Institute of Human Genetics of the Johannes Gutenberg University, Mainz, Germany, contributed to data extraction. Larissa Seidmann, Institute of Pathology of the Johannes Gutenberg University, Mainz, Germany, provided data and information on autopsies. Christoph Kampmann, Pediatric Cardiology Medical Center of the Johannes Gutenberg University, Mainz, Germany, contributed to data extraction. André Kidszun, Department of Neonatology of the Johannes Gutenberg University, Mainz, Germany, provided feedback on the report. Eva Mildenberger, Department of Neonatology of the Johannes Gutenberg University, Mainz, Germany, was responsible for designing the study protocol and provided feedback on the report. Catharina Whybra, Department of Neonatology of the Johannes Gutenberg University, Mainz, Germany, was responsible for designing the study protocol, conducting the search, interpreting results and screening potentially eligible studies. All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: Not applicable.

References

1. Society for Maternal-Fetal M, Norton, ME, Chauhan, SP, Dashe, JS. Society for maternal-fetal medicine (SMFM) clinical guideline #7: nonimmune hydrops fetalis. Am J Obstet Gynecol 2015;212:127–39. https://doi.org/10.1016/j.ajog.2014.12.018.Search in Google Scholar

2. Bellini, C, Donarini, G, Paladini, D, Calevo, MG, Bellini, T, Ramenghi, LA, et al.. Etiology of non-immune hydrops fetalis: an update. Am J Med Genet 2015;167A:1082–8. https://doi.org/10.1002/ajmg.a.36988.Search in Google Scholar

3. Bellini, C, Hennekam, RC, Fulcheri, E, Rutigliani, M, Morcaldi, G, Boccardo, F, et al.. Etiology of nonimmune hydrops fetalis: a systematic review. Am J Med Genet 2009;149A:844–51. https://doi.org/10.1002/ajmg.a.32655.Search in Google Scholar

4. Huang, HR, Tsay, PK, Chiang, MC, Lien, R, Chou, YH. Prognostic factors and clinical features in liveborn neonates with hydrops fetalis. Am J Perinatol 2007;24:33–8. https://doi.org/10.1055/s-2006-958158.Search in Google Scholar

5. Machin, GA. Hydrops revisited: literature review of 1,414 cases published in the 1980s. Am J Med Genet 1989;34:366–90. https://doi.org/10.1002/ajmg.1320340313.Search in Google Scholar

6. Whybra, C, Källén, K, Hansson, SR, Gunnarsson, R. Non-immune hydrops fetalis was rare in Sweden during 1997-2015, but cases were associated with complications and poor prognosis. Acta Paediatr 2020;109:2570–7.10.1111/apa.15260Search in Google Scholar

7. Steurer, MA, Peyvandi, S, Baer, RJ, MacKenzie, T, Li, BC, Norton, ME, et al.. Epidemiology of live born infants with nonimmune hydrops fetalis-insights from a population-based dataset. J Pediatr 2017;187:182–8 e3. https://doi.org/10.1016/j.jpeds.2017.04.025.Search in Google Scholar

8. Jauniaux, E. Diagnosis and management of early non-immune hydrops fetalis. Prenat Diagn 1997;17:1261–8. https://doi.org/10.1002/(sici)1097-0223(199712)17:13<1261::aid-pd292>3.0.co;2-c.10.1002/(SICI)1097-0223(199712)17:13<1261::AID-PD292>3.0.CO;2-CSearch in Google Scholar

9. Santolaya, J, Alley, D, Jaffe, R, Warsof, SL. Antenatal classification of hydrops fetalis. Obstet Gynecol 1992;79:256–9.Search in Google Scholar

10. Randenberg, AL. Nonimmune hydrops fetalis part II: does etiology influence mortality? Neonatal Netw 2010;29:367–80. https://doi.org/10.1891/0730-0832.29.6.367.Search in Google Scholar

11. Sudrie-Arnaud, B, Marguet, F, Patrier, S, Martinovic, J, Louillet, F, Broux, F, et al.. Metabolic causes of nonimmune hydrops fetalis: a next-generation sequencing panel as a first-line investigation. Clin Chim Acta 2018;481:1–8. https://doi.org/10.1016/j.cca.2018.02.023.Search in Google Scholar

12. Laterre, M, Bernard, P, Vikkula, M, Sznajer, Y. Improved diagnosis in nonimmune hydrops fetalis using a standardized algorithm. Prenat Diagn 2018;38:337–43. https://doi.org/10.1002/pd.5243.Search in Google Scholar PubMed

13. Hartge, DR, Weichert, J, Gembicki, M, Krapp, M. Confirmation of etiology in fetal hydrops by sonographic evaluation of fluid allocation patterns. Eur J Obstet Gynecol Reprod Biol 2015;195:128–32. https://doi.org/10.1016/j.ejogrb.2015.09.006.Search in Google Scholar PubMed

14. Australian Genomics Health Alliance Acute Care F, Lunke, S, Eggers, S, Wilson, M, Patel, C, Barnett, CP, et al.. Feasibility of ultra-rapid exome sequencing in critically ill infants and children with suspected monogenic conditions in the Australian public health care system. JAMA 2020;323:2503–11. https://doi.org/10.1001/jama.2020.7671.Search in Google Scholar PubMed PubMed Central

15. Sparks, TN, Lianoglou, BR, Adami, RR, Pluym, ID, Holliman, K, Duffy, J, et al.. Exome sequencing for prenatal diagnosis in nonimmune hydrops fetalis. N Engl J Med 2020;383:1746–56. https://doi.org/10.1056/nejmoa2023643.Search in Google Scholar

16. Schonfeld, M, Selig, M, Russo, A, Lindner, C, Kampmann, C, Mildenberger, E, et al.. Rapid detection by hydrops panel of Noonan syndrome with PTPN11 mutation (p.Thr73Ile) and persistent thrombocytopenia. Mol Genet Genomic Med 2020:e1174. https://doi.org/10.1002/mgg3.1174.Search in Google Scholar PubMed PubMed Central

17. Deng, Q, Fu, F, Yu, Q, Li, R, Li, F, Wang, D, et al.. Nonimmune hydrops fetalis: genetic analysis and clinical outcome. Prenat Diagn 2020;40:803–12.10.1002/pd.5691Search in Google Scholar PubMed

18. Whybra, C, Mengel, E, Russo, A, Bahlmann, F, Kampmann, C, Beck, M, et al.. Lysosomal storage disorder in non-immunological hydrops fetalis (NIHF): more common than assumed? Report of four cases with transient NIHF and a review of the literature. Orphanet J Rare Dis 2012;7:86. https://doi.org/10.1186/1750-1172-7-86.Search in Google Scholar PubMed PubMed Central

19. Gort, L, Granell, MR, Fernandez, G, Carreto, P, Sanchez, A, Coll, MJ. Fast protocol for the diagnosis of lysosomal diseases in nonimmune hydrops fetalis. Prenat Diagn 2012;32:1139–42. https://doi.org/10.1002/pd.3972.Search in Google Scholar PubMed

20. Burin, MG, Scholz, AP, Gus, R, Sanseverino, MT, Fritsh, A, Magalhaes, JA, et al.. Investigation of lysosomal storage diseases in nonimmune hydrops fetalis. Prenat Diagn 2004;24:653–7. https://doi.org/10.1002/pd.967.Search in Google Scholar PubMed

21. Kooper, AJ, Janssens, PM, de Groot, AN, Liebrand-van Sambeek, ML, van den Berg, CJ, Tan-Sindhunata, GB, et al.. Lysosomal storage diseases in non-immune hydrops fetalis pregnancies. Clin Chim Acta 2006;371:176–82. https://doi.org/10.1016/j.cca.2006.03.007.Search in Google Scholar PubMed

22. Bellini, C, Fulcheri, E, Rutigliani, M, Calevo, MG, Boccardo, F, Campisi, C, et al.. Immunohistochemistry in non-immune hydrops fetalis: a single center experience in 79 fetuses. Am J Med Genet 2010;152A:1189–96. https://doi.org/10.1002/ajmg.a.33191.Search in Google Scholar

23. Quinn, AM, Valcarcel, BN, Makhamreh, MM, Al-Kouatly, HB, Berger, SI. A systematic review of monogenic etiologies of nonimmune hydrops fetalis. Genet Med 2021;23:3–12. https://doi.org/10.1038/s41436-020-00967-0.Search in Google Scholar

24. Mone, F, Eberhardt, RY, Hurles, ME, McMullan, DJ, Maher, ER, Lord, J, et al.. Fetal hydrops and the Incremental yield of Next-generation sequencing over standard prenatal Diagnostic testing (FIND) study: prospective cohort study and meta-analysis. Ultrasound Obstet Gynecol 2021;58:509–18. https://doi.org/10.1002/uog.23652.Search in Google Scholar

25. Mardy, AH, Chetty, SP, Norton, ME, Sparks, TN. A system-based approach to the genetic etiologies of non-immune hydrops fetalis. Prenat Diagn 2019;39:732–50. https://doi.org/10.1002/pd.5479.Search in Google Scholar

26. Waring, GJ, Splitt, M, Robson, SC. Fetal hydrops: diagnosis and prognosis. Arch Dis Child 2019;104:209–10. https://doi.org/10.1136/archdischild-2018-315777.Search in Google Scholar

27. Adams, DR, Eng, CM. Next-generation sequencing to diagnose suspected genetic disorders. N Engl J Med 2018;379:1353–62. https://doi.org/10.1056/nejmra1711801.Search in Google Scholar

28. Lord, J, McMullan, DJ, Eberhardt, RY, Rinck, G, Hamilton, SJ, Quinlan-Jones, E, et al.. Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study. Lancet 2019;393:747–57. https://doi.org/10.1016/S0140-6736(18)31940-8.Search in Google Scholar

29. Sparks, TN, Thao, K, Lianoglou, BR, Boe, NM, Bruce, KG, Datkhaeva, I, et al.. Nonimmune hydrops fetalis: identifying the underlying genetic etiology. Genet Med 2019;21:1339–44. https://doi.org/10.1038/s41436-018-0352-6.Search in Google Scholar PubMed PubMed Central

30. Gilby, DM, Mee, JB, Kamlin, COF, Kornman, LH, Davis, PG, Manley, BJ. Outcomes following antenatal identification of hydrops fetalis: a single-centre experience from 2001 to 2012. Arch Dis Child Fetal Neonatal Ed 2019;104:F253–8. https://doi.org/10.1136/archdischild-2017-313604.Search in Google Scholar PubMed

31. Fukushima, K, Morokuma, S, Fujita, Y, Tsukimori, K, Satoh, S, Ochiai, M, et al.. Short-term and long-term outcomes of 214 cases of non-immune hydrops fetalis. Early Hum Dev 2011;87:571–5. https://doi.org/10.1016/j.earlhumdev.2011.04.015.Search in Google Scholar PubMed

Received: 2022-01-05
Accepted: 2022-03-10
Published Online: 2022-04-11
Published in Print: 2022-09-27

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Review
  3. Neonatal and child mortality – are they different in developing and developed countries?
  4. WAPM Guideline
  5. First trimester examination of fetal anatomy: clinical practice guideline by the World Association of Perinatal Medicine (WAPM) and the Perinatal Medicine Foundation (PMF)
  6. Original Articles – Obstetrics
  7. Symptoms of maternal psychological distress during pregnancy: sex-specific effects for neonatal morbidity
  8. Efficacy of the lactate dehydrogenase (LDH)/lymphocyte ratio (LLR) to reduce the need for X-ray in pregnant patients with COVID-19
  9. Attitude of pregnant and lactating women toward COVID-19 vaccination in Jordan: a cross-sectional study
  10. Association between maternal thyroid function and risk of gestational hypertension and preeclampsia
  11. Evaluation of umbilical cord immune cells in pregnancies with autoimmune disorders and/or methylenetetrahydrofolate reductase polymorphisms
  12. The association between induction of labour in nulliparous women at term and subsequent spontaneous preterm birth: a retrospective cohort study
  13. Transvaginally surgically treatment of early postpartum hemorrhage caused by lower uterine segment atony
  14. Value of soluble fms-like tyrosine kinase-1/placental growth factor test in third trimester of pregnancy for predicting preeclampsia in asymptomatic women
  15. Fetal growth regulation via insulin-like growth factor axis in normal and diabetic pregnancy
  16. Intrapartum cardiotocography in pregnancies with and without fetal CHD
  17. Racial and ethnic representation in 17-hydroxyprogesterone caproate preterm birth prevention studies: a systematic review
  18. Original Articles – Fetus
  19. Improved method for revising the Israel birthweight references
  20. A single center experience in 90 cases with nonimmune hydrops fetalis: diagnostic categories ‒ mostly aneuploidy and still often idiopathic
  21. Original Articles – Neonates
  22. Diagnosis of congenital infections in premature, low-birthweight newborns with intrauterine growth restriction caused by cytomegalovirus (CMV), herpes simplex virus (HSV), Parvo-B 19, and Zika virus: a systematic review
  23. The impact of COVID-19 on smoking cessation in pregnancy
  24. Letter to the Editor
  25. Early placenta previa percreta and treatment with supracervical abortion hysterectomy
Downloaded on 19.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpm-2022-0005/html
Scroll to top button